Loading clinical trials...
Loading clinical trials...
This study will assess the distribution of a microbicidal gel in the vagina and confirm the presence of bare spots. MRIs will be done with and without the addition of the MRI contrast Gadolinium to the microbicide in order to determine whether the bare spots are an artifact of the MRI technique.
Age
18 - 45 years
Sex
FEMALE
Healthy Volunteers
Yes
Reproductive Research Unit, U of Penn Medical Center
Philadelphia, Pennsylvania, United States
Start Date
June 1, 2005
Last Updated
October 25, 2005
6
Estimated participants
HEC placebo gel
DRUG
Lead Sponsor
Biosyn
Collaborators
NCT06694805
NCT04142047
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07428330